You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-36. Primary amphetamine use among new clients entering treatment (%), 2002 to 2007

Country	2002	2003	2004	2005	2006	2007
Czech Republic	50.7	55.0	58.4	59.7	61.7	63.6
Denmark	8.4	10.3	12.0	10.4	14.9	13.5
Latvia	11.0	14.0	24.5	23.8	22.3	20.3
Netherlands	3.6	4.8	6.0	7.0	7.5	6.9
Finland	31.7	31.8	29.4	29.0	23.0	22.9
Sweden	32.4	32.1	28.6	24.9	26.7	27.7

Notes:

Percentages are of new clients with known primary drug.

Only countries with available data are shown

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2008 — Standard table 34 See also Table TDI-4 and Table TDI-5 and See Table TDI-0] for details on sources.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)